Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S. - Report - MDSpire

Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.

  • By

  • Associated Press

  • June 3, 2026

  • 0 min

Share

Federal Charges Filed Against NIH Scientist and Research Fellow for Importing Inactivated Mpox Virus into the U.S.

Overview

Two scientists were charged with smuggling vials of deactivated mpox virus into the U.S. and lying about it during airport interviews.

Background

The importation of biological materials without proper authorization poses significant risks to public health and safety. Mpox, a viral disease that can cause serious illness, has seen a resurgence in recent years.

Data Highlights

No numerical or trial data was presented in the article.

Key Findings

  • Vincent Munster and Claude Kwe were charged with smuggling deactivated mpox virus into the U.S.
  • The scientists failed to declare the biological materials upon entry and did not obtain necessary permissions.
  • Munster denied having biological materials, claiming he had documentation on his laptop.
  • The incident occurred after their return from the Republic of Congo, where they had been conducting research.
  • Mpox has been confirmed to spread via sexual contact, leading to outbreaks in over 70 countries.

Clinical Implications

Healthcare professionals should remain vigilant regarding the protocols for importing biological materials.

Conclusion

The charges against the scientists were filed regarding the importation of biological materials.

Related Resources & Content

  1. Associated Press Health, AP News, 2023 -- Former NIH scientist sues Trump administration over research cuts
  2. Stat News, Stat News, 2026 -- A CDC page on mpox caught in political crosshairs
  3. Open Forum Infectious Diseases, Open Forum Infectious Diseases, 2022 -- Persistence of Monkeypox Virus on Frequently Touched Surfaces in Healthcare Environments
  4. CDC, CDC, 2026 -- Clinical Overview of Clade I and Clade II Monkeypox
  5. CDC, CDC, 2026 -- Tecovirimat (TPOXX) for Treatment of Monkeypox
  6. CDC, CDC, 2026 -- Vaccine for Monkeypox Prevention in the United States
  7. Infection — Initial Human Monkeypox Infections in Germany: Clinical and Virological Insights
  8. Clinical Overview of Clade I and Clade II Monkeypox | Monkeypox | CDC
  9. Tecovirimat (TPOXX) for Treatment of Monkeypox | Monkeypox | CDC
  10. Vaccine for Monkeypox Prevention in the United States | Monkeypox | CDC
  11. Laboratory Biosafety for Handling and Processing Monkeypox Specimens | Monkeypox | CDC

Original Source(s)

Related Content